Sulfasalazine belongs to a group of drugs called disease-modifying anti-rheumatic drugs (DMARDs). It reduces inflammation in the body, particularly in the joints and intestines, by suppressing the immune system’s response, thereby alleviating symptoms and preventing further damage.